August 07, 2024
After accumulating more than half a billion dollars of deficits over its history, VBI Vaccines, a developer of COVID-19 and hepatitis B vaccines, was unable to avoid bankruptcy court as it sought to consummate a sale of some of its assets.
August 02, 2024
A Delaware bankruptcy judge scheduled a late August hearing to consider recognition of a vaccine developer's insolvency proceedings in Canada.